Literature DB >> 29172866

Radiosensitization of ultrasmall GNP-PEG-cRGDfK in ALTS1C1 exposed to therapeutic protons and kilovoltage and megavoltage photons.

Milad Enferadi1, Sheng-Yung Fu2,3, Ji-Hong Hong3,4, Chuan-Jong Tung1,5, Tsi-Chian Chao1,5, Shiaw-Pyng Wey1, Chun-Hui Chiu6, Chun-Chieh Wang3, Mahdi Sadeghi7.   

Abstract

PURPOSE: One of the promising radiosensitizers is the ultrasmall gold nanoparticle (GNP) with a hydrodynamic diameter <3 nm. We studied functionalized ultrasmall GNPs (1.8 nm diameter) coated by polyethylene glycol (PEG) and conjugated with cyclic RGDfK (2.6 nm hydrodynamic diameter) for targeting of alpha(v) beta(3) integrin (αvβ3) in the murine ALTS1C1 glioma cell line.
MATERIALS AND METHODS: We investigated the uptake, toxicity and radiosensitivity of GNP-PEG-cRGDfKs in ALTS1C1 cells exposed to protons, kilovoltage photons and megavoltage photons. The in vitro uptake and toxicity of GNPs in the hepatocytes and Kupffer cells were assessed for murine AML12 hepatocyte and RAW 264.7 macrophage cell lines. The in vivo biodistribution of GNPs in the ALTS1C1 tumor model was tested using the inductively coupled plasma mass spectrometry.
RESULTS: Results indicated GNPs accumulated in the cytoplasm with negligible toxicity for a moderate concentration of GNPs. Observed sensitizer enhancement ratios and dose enhancement factors are 1.21-1.66 and 1.14-1.33, respectively, for all radiations.
CONCLUSION: Ultrasmall GNP-PEG-cRGD can be considered as a radiosensitizer. For radiotherapy applications, the delivery method should be developed to increase the GNP uptake in the tumor and decrease the uptakes in undesirable organs.

Entities:  

Keywords:  ALTS1C1; GNP; cyclic RGD; proton therapy; radiosensitization

Mesh:

Substances:

Year:  2018        PMID: 29172866     DOI: 10.1080/09553002.2018.1407462

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  5 in total

Review 1.  Gold Nanoparticles as a Potent Radiosensitizer: A Transdisciplinary Approach from Physics to Patient.

Authors:  Sébastien Penninckx; Anne-Catherine Heuskin; Carine Michiels; Stéphane Lucas
Journal:  Cancers (Basel)       Date:  2020-07-23       Impact factor: 6.639

Review 2.  Targeting Integrins in Cancer Nanomedicine: Applications in Cancer Diagnosis and Therapy.

Authors:  Ping-Hsiu Wu; Abayomi Emmanuel Opadele; Yasuhito Onodera; Jin-Min Nam
Journal:  Cancers (Basel)       Date:  2019-11-13       Impact factor: 6.639

Review 3.  Metal-Based Nanostructured Therapeutic Strategies for Glioblastoma Treatment-An Update.

Authors:  Agata M Gawel; Ravi Singh; Waldemar Debinski
Journal:  Biomedicines       Date:  2022-07-05

4.  Differential Radiosensitizing Effect of 50 nm Gold Nanoparticles in Two Cancer Cell Lines.

Authors:  Miguel Ángel Pérez-Amor; Leonardo Barrios; Gemma Armengol; Joan Francesc Barquinero
Journal:  Biology (Basel)       Date:  2022-08-09

5.  Impact of the Spectral Composition of Kilovoltage X-rays on High-Z Nanoparticle-Assisted Dose Enhancement.

Authors:  Maria A Kolyvanova; Alexandr V Belousov; Grigorii A Krusanov; Alexandra K Isagulieva; Kirill V Morozov; Maria E Kartseva; Magomet H Salpagarov; Pavel V Krivoshapkin; Olga V Dement'eva; Victor M Rudoy; Vladimir N Morozov
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.